R
Robert A. Giacobbe
Researcher at Merck & Co.
Publications - 55
Citations - 2121
Robert A. Giacobbe is an academic researcher from Merck & Co.. The author has contributed to research in topics: Aspergillus fumigatus & Endothelin receptor. The author has an hindex of 25, co-authored 55 publications receiving 1980 citations.
Papers
More filters
Journal ArticleDOI
Discovery of Novel Antifungal (1,3)-β-d-Glucan Synthase Inhibitors
Janet C. Onishi,Maria S. Meinz,John R. Thompson,James E. Curotto,Sarah Dreikorn,Mark Rosenbach,Cameron M. Douglas,George K. Abruzzo,Amy M. Flattery,Leopold Kong,Angeles Cabello,Francisca Vicente,Fernando Pelaez,Maria Teresa Diez,Isabel Martin,Gerald F. Bills,Robert A. Giacobbe,Anne W. Dombrowski,Robert E. Schwartz,Sandra A. Morris,Guy H. Harris,A. Tsipouras,Kenneth E. Wilson,Myra B. Kurtz +23 more
TL;DR: Results of natural-product screening by a series of newly developed methods has led to the identification of four acidic terpenoid (1,3)-β-d-glucan synthase inhibitors, which have limited oral bioavailability and in vitro antifungal activity comparable to that of L-733560, a close analogue of MK-0991.
Journal ArticleDOI
Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species
Frank C. Odds,Mary Motyl,Roberto Andrade,Jacques Bille,Emilia Cantón,Manuel Cuenca-Estrella,Amanda Denise Davidson,Christian Durussel,David Ellis,Elyse Foraker,Annette W. Fothergill,Mahmoud A. Ghannoum,Robert A. Giacobbe,Miguel Gobernado,Rosemary Handke,Michel Laverdière,Wendy Lee-Yang,William G. Merz,Luis Ostrosky-Zeichner,Javier Pemán,Sophia Perea,John R. Perfect,Michael A. Pfaller,Laurie A. Proia,John H. Rex,John H. Rex,Michael G. Rinaldi,Juan L. Rodriguez-Tudela,Wiley A. Schell,Christine E. Shields,Deanna A. Sutton,Paul E. Verweij,David W. Warnock +32 more
TL;DR: The minimal effective concentration end point, defined as the lowest caspofungin concentration yielding conspicuously aberrant hyphal growth, gave excellent reproducibility for data from 14 of the 17 participating laboratories, and the best interlaboratory separation of Candida isolates of known high and low susceptibility to casp ofungin.
Journal ArticleDOI
The discovery of australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity.
Suzanne M. Mandala,Rosemary A. Thornton,Beth R. Frommer,James E. Curotto,Walter Rozdilsky,Myra B. Kurtz,Robert A. Giacobbe,Gerald F. Bills,M. Angeles Cabello,Isabel Martin,Fernando Pelaez,Guy H. Harris +11 more
TL;DR: Australifungin exhibited broad spectrum antifungal activity against human pathogenic fungi with MICs against Candida spp.
Journal ArticleDOI
The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organisms.
Fernando Pelaez,Angeles Cabello,Gonzalo Platas,Maria Teresa Diez,Antonio González del Val,Angela Basilio,Isabel Martán,Francisca Vicente,Gerald F. Bills,Robert A. Giacobbe,Robert E. Schwartz,Janet C. Onishi,Maria S. Meinz,George K. Abruzzo,Amy M. Flattery,Li Kong,Myra B. Kurtz +16 more
TL;DR: In this paper, a new triterpene glycoside, called Caspofungin acetate (CFA), was detected in a culture belonging to the form-genus Hormonema, isolated from leaves of Juniperus communis.
Journal ArticleDOI
L-671,329, a new antifungal agent. I: Fermentation and isolation
TL;DR: A new lipopeptide antifungal agent, similar to echinocandin B, has been isolated from Zalerion arboricola and studies indicate that L-671,329 is produced under both solid and liquid fermentation conditions.